The protocol of AmoyDx® ddCAP (dual directional capture) kits encompasses a two-day workflow. It is based on hybrid capture technology and therefore enables the detection of unknown gene fusions.
Product | Manufacturer | Amount | Status | Order no. | Info | |
---|---|---|---|---|---|---|
AmoyDx® Comprehensive Panel | AmoyDx | 1 Kit (24 Tests) | Bulk | RUO | ADX-NCP04-R | |
AmoyDx® Essential NGS Panel | AmoyDx | 1 Kit (24 Tests) | Bulk | CE/IVD | ADX-NLC01 | |
AmoyDx® FGFR1-4 NGS Panel | AmoyDx | 1 Kit (24 Tests) | Bulk | RUO | ADX-NFP08-R | |
AmoyDx® HRR Liquid NGS Panel | AmoyDx | 1 Kit (24 Tests) | Bulk | RUO | ADX-NHLP10-R | |
AmoyDx® Master Panel | AmoyDx | 1 Kit (24 Tests) | Bulk | RUO | ADX-NMP07-R |
Detection of unknown gene fusion partners
UID-sequences (unique identifier sequences) efficiently identify PCR errors during data analysis
Sequencing data analysis on the AmoyDx® ANDAS workstation, a cloud-independent stand-alone system for high data security
Suitable for many common Illumina sequencing platforms
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.